A comparative study of combination octreotide plus methylprednisolone with octreotide and placebo on prevention of post-endoscopic retrograde cholangiopancreatography (ERCP)pancreatitis

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Annals of Gastroenterology

• Publication date

  2007-03-23

• Fields of study

  Medicine

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial.

  1999cited by this paper
• Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis.

  1998cited by this paper
• Complications of endoscopic biliary sphincterotomy.

  1997cited by this paper
• Long‐Term Prophylactic Administration of Octreotide Reduces the Rise in Serum Amylase After Endoscopic Procedures on Vater's Papilla

  1996cited by this paper
• The role of corticosteroids in the prevention of post-ERCP pancreatitis

  1996cited by this paper
• Intrapancreatic dexamethasone does not prevent sphincterotomy-induced pancreatitis in a canine model

  1996cited by this paper
• Complications of endoscopic biliary sphincterotomy.

  1996cited by this paper
• Pure cut electrocautery current for sphincterotomy causes less post-procedure pancreatitis than blended current.

  1995cited by this paper
• The relative effectiveness of somatostatin and octreotide therapy in pancreatic disease

  1995cited by this paper
• Infusion of C1-inhibitor plasma concentrate prevents hyperamylasemia induced by endoscopic sphincterotomy.

  1995cited by this paper
• Use of corticosteroids in the prevention of post-ERCP pancreatitis.

  1995cited by this paper
• Post-ERCP pancreatitis: randomized, prospective study comparing a low- and high-osmolality contrast agent.

  1994cited by this paper
• Intraluminal pancreatic candidiasis presenting as recurrent pancreatitis.

  1993cited by this paper
• A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.

  1993cited by this paper
• Pancreatitis after sphincter of Oddi manometry.

  1992cited by this paper
• A multicenter, randomized, controlled trial to evaluate the effect of prophylactic octreotide on ERCP-induced pancreatitis.

  1992cited by this paper
• New perspectives on acute pancreatitis.

  1992cited by this paper
• Does the somatostatin analogue octreotide protect against ERCP induced pancreatitis?

  1992cited by this paper
• Pancreatitis following bile duct sphincter of Oddi manometry: utility of the aspirating catheter.

  1992cited by this paper
• Can somatostatin prevent injection pancreatitis after ERCP?

  1992cited by this paper
• Different contrast agents and development of pancreatitis after endoscopic retrograde pancreatography.

  1992cited by this paper
• Endoscopic sphincterotomy complications and their management: an attempt at consensus.

  1991influential reference
• Somatostatin prevents acute pancreatitis after pancreatic duct sphincter hydrostatic balloon dilation in patients with idiopathic recurrent pancreatitis.

  1991cited by this paper
• A comparative study of contrast agents for endoscopic retrograde pancreatography.

  1991cited by this paper
• Intracellular Events in the Pathogenesis of Acute Pancreatitis

  1991influential reference
• The effect of long-acting somatostatin analogue on enzyme changes after endoscopic pancreatography.

  1991cited by this paper
• ERCP‐ and Endoscopic Sphincterotomy‐Induced Pancreatitis

  1991influential reference
• Pancreatitis after sphincter of Oddi manometry.

  1990cited by this paper
• Allergic Reaction to Contrast Medium after Endoscopic Retrograde Pancreatography

  1990cited by this paper
• Septicemia after Endoscopic Retrograde Cholangiopancreatography

  1990cited by this paper
• Local administration of human pancreatic secretory trypsin inhibitor prevents the development of experimental acute pancreatitis in rats and dogs.

  1989cited by this paper
• Endoscopic papillo-sphincterotomy: Prevention of pancreatic reaction by somatostatin

  1988cited by this paper
• Prevention of pancreatic reactions by bolus somatostatin administration in patients undergoing endoscopic retrograde cholangio-pancreatography and endoscopic sphincterotomy.

  1988cited by this paper
• Effect of somatostatin analogue (SMS 201-995, Sandostatin) on pancreatic secretion in humans.

  1987cited by this paper
• A Randomised, Prospective Study Comparing Two Contrast Media in ERCP

  1987cited by this paper
• Absorption of iodized contrast media during ERCP.

  1986cited by this paper
• Effect of a New Somatostatin Analogue on Pancreatic Function in Healthy Volunteers

  1986cited by this paper
• Effects of somatostatin and a long‐acting somatostatin analogue on the prevention and treatment of experimentally induced acute pancreatitis in the rat

  1985cited by this paper
• ERCP and allergic reactions to iodized contrast media.

  1985cited by this paper
• Hyperamylasemia after ERCP with ionic and non-ionic contrast media.

  1985cited by this paper
• Post-ERCP pancreatitis: association with urographic visualization during ERCP.

  1985cited by this paper
• The immediate effects of retrograde pancreatography on the pancreas.

  1984cited by this paper
• Absorption of contrast medium during ERCP

  1983cited by this paper
• Acute pancreatitis following endoscopic retrograde cholangiopancreatography.

  1983cited by this paper
• Glucocorticoid-induced elevations of C1-esterase inhibitor: a mechanism for protection against lethal dose range contrast challenge in rabbits.

  1980cited by this paper
• Contrast absorption and pancreatic inflammation following experimental ERCP.

  1979cited by this paper
• Secretin/cholecystokinin-stimulated secretion of trypsinogen and trypsin inhibitor in pure human pancreatic juice collected by endoscopic retrograde catheterization.

  1978cited by this paper
• Detection of bacterial infection of the pancreatic ducts in patients with pancreatitis and pancreatic cancer during endoscopic cannulation of the pancreatic duct.

  1977cited by this paper
• An Experimental and Clinical Study

  1966cited by this paper

• Octreotide and Somatostatin as Prophylactic Agents Against Postendoscopic Retrograde Cholangiopancreatography Pancreatitis: An Updated Comprehensive Systematic Review and Meta-Analysis.

  2025cites this paper